Conclusions: Both thrombin and plasmin were able to induce proteoglycan release in a dose-dependent manner. PAR1 and PAR2 antagonists were not able to inhibit the thrombin-and plasmin induced proteoglycan release. Furthermore, the PAR agonists TFLLR-NH 2 and SLIGKV failed to induce proteoglycan release. This suggests that both thrombin and plasmin induce proteoglycan release and that both are able to damage the human cartilage in a PAR-independent manner. In previous work, we demonstrated that hypertrophic differentiation of chondrocytes is initiated by serum-enriched medium in long-term culture in alginate beads suggesting a role played by blood supply in the hypertrophic differentiation of chondrocytes in OA. This study aims to investigate the production of Bone SialoProtein (BSP), an angiogenesis enhancer known to promote endothelial cell attachment and migration, during hypertrophic differentiation of OA chondrocytes and its expression in OA cartilage according to the severity of the lesions by immunohistochemistry. This work was supported by an OARSI scholarship grant. Methods: Articular OA chondrocytes were cultured for 28 days in alginate beads in culture medium containing 2% Ultroser G (UG) or 10% Fetal Bovine Serum (FBS). DNA was quantified by fluorimetry. The expression of BSP and hypertrophic differentiation marker COL10A1 was evaluated by RT-PCR. Alkaline phosphatase (AP) activity and 5 phosphodiesterase activity of NTPPPH were quantified by specific enzymatic methods. Western Blot analysis was performed from chondrocyte protein extracts with anti-BSP antibody (LFMb-24). Human bone and cartilage samples from 9 post-mortem (PM) individuals and 24 patients undergoing total knee joint replacement for OA (TKR) were formalin-fixed, EDTA-decalcified and wax embedded. Five mm tissue sections were cut and stained. Macroscopic chondropathy score described previously by Walsh et al. and the modified Mankin score were respectively used to establish macroscopic and microscopic chondropathy scores for individual knees. BSP was immunolocalized in cartilage using anti-BSP monoclonal antibody (LFMb-25) and anti-BSP polyclonal antibody (ab52128) to confirm the specificity of staining. A scoring system was established according to the location of the stained cells in cartilage (0: no staining -1: staining in the superficial layer -2: staining in the middle layer -3: staining in the deep layer). All histological scoring was undertaken twice blinded to patient group, using a Zeiss Axioscop-50 microscope. Data were analyzed using GraphPad Prism software, version 5. Associations between variables were reported as Spearman's rank correlation coefficients (r). Results: In alginate beads, chondrocytes cultured in serumsupplemented medium underwent a hypertrophic differentiation process characterized by the increased expression of hypertrophic differentiation markers. In the same manner, the expression of BSP increased in FBS with long-term culture and was associated with markers of chondrocytes hypertrophy; COL10A1 (r = 0.67; p = 0.005), AP (r = 0.8; p = 0.0002) and NTPPPH (r = 0.68; p = 0.004). After 21 days, BSP was also detected in protein extracts of chondrocytes cultured in serum but not in UG. BSP-immunoreactive chondrocytes were localized at increased depth in cartilage from OA joints (2.3±0.63) than from PM controls (0.56±0.54), (p = 0.005). The expression of BSP in patients with OA was associated with the severity of macroscopic cartilage lesions (r = 0.5; p = 0.01). Highly significant correlations were also observed with the modified Mankin score (r = 0.71; p < 0.0001) and with the individual scoring criteria of cartilage surface integrity (r = 0.51; p = 0.01), chondrocyte appearance (r = 0.44; p = 0.03) and proteoglycan loss (r = 0.61; p = 0.001). Conclusions: Genetic and protein expression of BSP are associated with hypertrophic differentiation of chondrocytes in OA. Location of BSP in OA cartilage is clearly associated with macroscopic and microscopic cartilage lesion severity. BSP may be an important factor in cartilage degradation and its role as an angiogenesis enhancer in OA is still to be demonstrated. 31-40 (n = 6), 41-50 (n = 18), 51-60 (n = 21), 61-70 (n = 22), 71-80 (n = 20), 81-90 (n = 26) and >91 (n = 9). All cartilage compartments were macroscopically assessed according to the ICRS mapping system by using a modified Outerbridge grading system. Menisci and ACL were evaluated macroscopically and by histopathology. Synovium histopathology was assessed using a modified Krenn grading system for chronic synovitis. Osteophytosis was macroscopically assessed.
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COMMON AND EARLY CARTILAGE DEGENERATION PATTERNS IN AGING AND OSTEOARTHRITIC HUMAN KNEES

Results:
We found a strong correlation between cartilage, meniscus, and ACL degeneration with aging. The earliest cartilage lesions were detected in the central area of the lateral tibial plateau that is not covered by the meniscus, followed by changes in patella and trochlea. Degeneration in the medial femoral condyle appeared later than in the tibia plateau but progressed rapidly to become the most severely affected among all articular surfaces. On the other hand, degeneration in the lateral femoral condyle progressed less rapidly in all age groups. In the lateral TFJ, more knees had a higher tibial than femoral average grade at all ages. This pattern was similar but reversed with aging in the medial TFJ. Degeneration of the meniscus-covered tibia surface correlated with increased meniscus degeneration. A common macroscopic pattern (33%) was degeneration in tibia and meniscus with a normal-appearing femoral condyle. In 14% we found degenerative changes in the tibia while menisci and femoral condyles were normal. In 18% we found a macroscopically normal meniscus while there were degenerative changes in tibia (uncovered portion) and femoral condyle. ACL scores increase with cartilage degeneration at all stages of OA development and correlated with cartilage as well as meniscus degeneration, especially in the medial compartment. Moderate and severe OA groups showed significantly higher ACL substance scores than the minimal/mild OA groups. Synovitis correlated with cartilage degeneration and the presence of osteophytes. In our donor population every knee with osteophytes was accompanied by synovitis. Conclusions: By examining younger age groups, we were able to identify early patterns of cartilage degeneration. Our data suggest that in younger subjects the lateral tibia plateau shows the earliest and most severe degeneration. Contrary to the notion that the medial TFJ compartment in severe OA is most affected, we found that the lateral tibia plateau is affected the earliest. The uncovered part of the tibia plateau degenerated first, followed by early surface degeneration in the inner rim of the menisci. Degeneration of the covered tibia region increased with cumulative meniscus degeneration, supporting the protective role of menisci. This cross-sectional study emphasizes the importance of interaction of the different joint tissues in OA initiation and progression and defines specific regions in the joint for future studies on biomechanical and cellular factors that determine early stages of OA initiation to reveal novel targets for preventing or delaying OA. 
COMPARISON OF SYNOVIAL FLUID ARGS CONCENTRATIONS AT BASELINE AND ONE-YEAR POST-ACL RECONSTRUCTION COMPARED TO HEALTHY, MATCHED CONTROLS
